SR-BI and Antiviral Treatment Response in HCV

NCT02714712 · clinicaltrials.gov ↗

COMPLETED

Status

309

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Peginterferon alfa-2a

Sponsor

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation